92 related articles for article (PubMed ID: 2973592)
1. [Role of ceftazidime in severe infections in children. Review of the literature].
Bégué P; Quinet B
Presse Med; 1988 Oct; 17(37):1944-7. PubMed ID: 2973592
[TBL] [Abstract][Full Text] [Related]
2. [Probabilistic treatment with ceftazidime of severe infections in children].
Bégué P
Presse Med; 1988 Oct; 17(37):1985-7. PubMed ID: 2973603
[TBL] [Abstract][Full Text] [Related]
3. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
[TBL] [Abstract][Full Text] [Related]
4. Ceftazidime therapy for serious infections.
Bint AJ; Constable J; Patton KR; Constable FL
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():115-21. PubMed ID: 6352613
[TBL] [Abstract][Full Text] [Related]
5. [Clinical results of the treatment of bacterial infections in children with ceftazidime].
Zoch-Zwierz W; Rudobielska M; Wierciński R; Winiecka W; Tomaszewska B
Pol Tyg Lek; 1989 Apr; 44(17):390-3. PubMed ID: 2696939
[TBL] [Abstract][Full Text] [Related]
6. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
Principi N; Marchisio P
J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
[TBL] [Abstract][Full Text] [Related]
7. [Ceftazidime for the treatment of infections in neutropenic children].
Leverger G; Arlet G; Bancillon A; Schaison G
Presse Med; 1988 Oct; 17(37):1974-6. PubMed ID: 2973600
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ceftazidime in the treatment of 80 infectious episodes in compromised children.
Viscoli C; Gargani G; Facco F; Mantero E; Tuo P; Giacchino R; Campelli A; Nantron M; Perlino G
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):629-34. PubMed ID: 3908333
[TBL] [Abstract][Full Text] [Related]
9. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
[TBL] [Abstract][Full Text] [Related]
10. [Clinical pharmacology of ceftazidime in childhood].
Sereni F; Rusconi F; Caccamo M; Boccazzi A; Cambisano W; Padoan R
G Ital Chemioter; 1984; 31(3):223-7. PubMed ID: 6399037
[No Abstract] [Full Text] [Related]
11. [Ceftazidime in common infections in childhood. Experience in 262 cases].
Fanos V; Fostini R; Panebianco R; Danieli D
Clin Ter; 1991 Jun; 137(5):327-32. PubMed ID: 1832605
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of pyocyanic bacillus superinfections in children with cystic fibrosis using a new cephalosporin: ceftazidime].
Labbé A; Sablayrolles B; Dechamps C; Sirot J; Marty N
Ann Pediatr (Paris); 1986 Sep; 33(7):625-8. PubMed ID: 3096185
[No Abstract] [Full Text] [Related]
13. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of ceftazidime in paediatrics.
Assael BM; Boccazzi A; Caccamo ML; Giunta A; Marini A; Padoan R; Rusconi F; Sereni F
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():341-6. PubMed ID: 6352640
[No Abstract] [Full Text] [Related]
15. The efficacy, safety and tolerance of ceftazidime for the treatment of bacterial infections in the elderly.
Vozza A; Zerman AM; Bertoni L; Cattini GC; Tosto L; Greco N; Romano F; Panebianco R; Benedetti M
J Hosp Infect; 1990 Apr; 15 Suppl A():87-9. PubMed ID: 1971652
[TBL] [Abstract][Full Text] [Related]
16. Ceftazidime in severe infections: a Swiss multicentre study.
Francioli P; Clément M; Geroulanos S; von Graevenitz A; Luthy R; Regamey C; Stalder H; Vogt M; Waldvogel FA
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
[TBL] [Abstract][Full Text] [Related]
17. An open study of the use of ceftazidime in Gram-negative infections.
Wardle JK; Snow MH; Ingham HR; Selkon JB
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():389-93. PubMed ID: 6352650
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with ceftazidime in urology in Japan.
Kawamura N
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():65-70. PubMed ID: 6352657
[TBL] [Abstract][Full Text] [Related]
19. Ceftazidime in cystic fibrosis.
Gordts B; Dab I; Butzler JP
Lancet; 1982 Jun; 1(8285):1355. PubMed ID: 6123654
[No Abstract] [Full Text] [Related]
20. Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
Pechère JC; Delisle R
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():181-8. PubMed ID: 6352619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
